C
AGN

Cerebellum’s Allergan plc AGN Stock Holding History

Cerebellum’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,256
Closed -$3.31M – 639
2020
Q2 		$3.31M Buy
+20,256
New +$3.76M 2.35% 19
2018
Q1 		– Sell
-20,256
Closed -$3.31M – 566
2017
Q4 		$3.31M Buy
+20,256
New +$3.63M 2.35% 19

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

Cerebellum's AGN Position: Q3 2020 in Review

Cerebellum sold out of Allergan plc (AGN) in Q3 2020, closing a stake of 20,256 shares — an estimated $3.31M sold.

Cerebellum first reported a position in AGN in Q4 2017 and held it in 2 quarters. The position peaked at $3.31M in Q2 2020. 3 funds tracked by Wall St. Rank hold AGN as of Q3 2020.

  • Cerebellum reported no remaining Allergan plc position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 20,256 Allergan plc shares in Q3 2020, an estimated $3.31M.
  • Cerebellum first reported a position in Allergan plc in Q4 2017 and held it in 2 quarters.
  • Cerebellum's Allergan plc position peaked at $3.31M in Q2 2020.
  • 3 funds tracked by Wall St. Rank held Allergan plc as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.